Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMP Study in Women (HVTN 703/HPTN 081)
NCT02568215Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2016
- Primary completion
- Mar 2021
- Modality
- Anti-infectious Disease mAbs
- Countries
- 7
01
Overview
A Phase 2 trial of VRC01 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by National Institute of Allergy and Infectious Diseases. Started May 2016; status: completed.
02
Drugs
VRC01
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02568215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568215.